Home-based Acute Care for Older Persons Initiated by the Emergency Medical and Ambulance Services - a Retrospective Observation of Effects on Healthcare Utilisation and Mortality

March 10, 2026 updated by: Vastra Gotaland Region

This observational study aims to examine outcomes of home-based acute care delivered by a mobile healthcare team in persons aged 75 years and older following an episode of acute illness.

The study will assess whether home-based acute care initiated by the emergency medical dispatch centre or ambulance services is non-inferior to emergency department care with regard to care needs and mortality.

Study Overview

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden
        • Sahlgrenska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of persons aged 75 years and older with an acute illness who contact the emergency number (112) and are assessed by the Emergency Medical Dispatch Centre or ambulance services, and who subsequently receive either home-based acute care from a mobile healthcare team or care at the emergency department.

Description

Inclusion Criteria:

  • Contact with the emergency number (112), followed by either a telephone assessment by the Emergency Medical Dispatch Centre or an in-home assessment by an ambulance nurse
  • Home-based acute care a weekday between 8 AM - 4 PM
  • Emergency-department care weeknight 4 PM - 8 AM or weekends
  • Registered residence in one of the municipalities of Gothenburg, Mölndal, Partille, or Härryda

Exclusion Criteria:

  • Immediate conditions requiring hospital care
  • Care at the emergency department or by a mobile primary care team occurring more than 24 hours after assessment by the Emergency Medical Dispatch Centre or ambulance services
  • Individuals who have already been assessed by a physician and/or have a written referral to the emergency department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Home-based acute care
Home-based acute care from a mobile healthcare team
Emergency department care
Home-based acute care from a mobile healthcare team

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Need of hospital-based care
Time Frame: within 30 days
within 30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

March 10, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 16, 2026

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made publicly available due to privacy and legal restrictions.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mortality

Clinical Trials on Type of care pathway

Subscribe